172 related articles for article (PubMed ID: 34059348)
1. OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer.
Frangou E; Bertelli G; Love S; Mackean MJ; Glasspool RM; Fotopoulou C; Cook A; Nicum S; Lord R; Ferguson M; Roux RL; Martinez M; Butcher C; Hulbert-Williams N; Howells L; Blagden SP
Gynecol Oncol; 2021 Aug; 162(2):431-439. PubMed ID: 34059348
[TBL] [Abstract][Full Text] [Related]
2. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression.
Hassani Alimolk F; McDonald FEJ; Asghari-Jafarabadi M; Ahmadi F; Zenoozian S; Lashkari M; Patterson P
Psychooncology; 2024 Apr; 33(4):e6339. PubMed ID: 38653573
[TBL] [Abstract][Full Text] [Related]
4. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two group therapies to reduce fear of progression in cancer patients.
Herschbach P; Book K; Dinkel A; Berg P; Waadt S; Duran G; Engst-Hastreiter U; Henrich G
Support Care Cancer; 2010 Apr; 18(4):471-9. PubMed ID: 19865833
[TBL] [Abstract][Full Text] [Related]
6. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
[TBL] [Abstract][Full Text] [Related]
7. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
8. Fear of cancer progression in patients with stage IA malignant melanoma.
Wagner T; Augustin M; Blome C; Forschner A; Garbe C; Gutzmer R; Hauschild A; Heinzerling L; Livingstone E; Loquai C; Schadendorf D; Terheyden P; Mueller-Brenne T; Kähler KC
Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12901. PubMed ID: 30126009
[TBL] [Abstract][Full Text] [Related]
9. Effects of a Video Sequence Based Intervention on Anxiety, Fatigue and Depression in Cancer Patients: Results of a Randomized Controlled Trial.
Neubert S; Schlecht S; Meng K; Rabe A; Jentschke E
Integr Cancer Ther; 2023; 22():15347354231153172. PubMed ID: 36799503
[TBL] [Abstract][Full Text] [Related]
10. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
11. The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial.
Brabyn S; Araya R; Barkham M; Bower P; Cooper C; Duarte A; Kessler D; Knowles S; Lovell K; Littlewood E; Mattock R; Palmer S; Pervin J; Richards D; Tallon D; White D; Walker S; Worthy G; Gilbody S
Health Technol Assess; 2016 Nov; 20(89):1-64. PubMed ID: 27922448
[TBL] [Abstract][Full Text] [Related]
12. Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy.
Wen Q; Shao Z; Zhang P; Zhu T; Li D; Wang S
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():85-91. PubMed ID: 28738296
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
15. Fear of disease progression and relevant correlates in acute leukemia patients prior to allogeneic hematopoietic stem cell transplantation.
Thiele S; Goebel S; Kröger N; Pedersen A
Psychooncology; 2020 Aug; 29(8):1248-1254. PubMed ID: 32323380
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the Fear of Progression Questionnaire for parents of children with cancer (FoP-Q-SF/PR).
Clever K; Schepper F; Pletschko T; Herschbach P; Christiansen H; Martini J
J Psychosom Res; 2018 Apr; 107():7-13. PubMed ID: 29502766
[TBL] [Abstract][Full Text] [Related]
17. Problem-solving therapy to improve depression scores among older hemodialysis patients: a pilot randomized trial.
Erdley SD; Gellis ZD; Bogner HA; Kass DS; Green JA; Perkins RM
Clin Nephrol; 2014 Jul; 82(1):26-33. PubMed ID: 24755106
[TBL] [Abstract][Full Text] [Related]
18. Improvement in sexual function after ovarian cancer: Effects of sexual therapy and rehabilitation after treatment for ovarian cancer.
Bober SL; Recklitis CJ; Michaud AL; Wright AA
Cancer; 2018 Jan; 124(1):176-182. PubMed ID: 28881456
[TBL] [Abstract][Full Text] [Related]
19. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.
Piccirillo MC; Scambia G; Bologna A; Signoriello S; Vergote I; Baumann K; Lorusso D; Murgia V; Sorio R; Ferrandina G; Sacco C; Cormio G; Breda E; Cinieri S; Natale D; Mangili G; Pisano C; Cecere SC; Di Napoli M; Salutari V; Raspagliesi F; Arenare L; Bergamini A; Bryce J; Daniele G; Gallo C; Pignata S; Perrone F
Ann Oncol; 2018 May; 29(5):1189-1194. PubMed ID: 29462248
[TBL] [Abstract][Full Text] [Related]
20. [Cognitive-Behavioral Group Therapy Addressing Fear of Progression in Cancer Out-Patients].
Rudolph B; Wünsch A; Herschbach P; Dinkel A
Psychother Psychosom Med Psychol; 2018 Jan; 68(1):38-43. PubMed ID: 28718864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
